With its due complexity and pervasiveness, research on disorders afflicting the central nervous system is challenging and potentially rewarding. Work in this area assumes significance as most of the drugs are palliative than curative. Sushmi Dey analyses…
Testing a siddha drug
Suresh Kumar S gives details of the anti-inflammatory studies of an indigenous siddha formulation.
Zydus Cadila’s cardio drug gets tentative approval
Zydus Cadila received tentative approval from USFDA to market Pravastatin Sodium tablets, 10 milligram, 20 milligram, 40 milligram and 80 milligram in the US market.